Sep 12, 2024
Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference
Sep 03, 2024
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
Aug 28, 2024
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
Aug 07, 2024
Keros Therapeutics Reports Second Quarter 2024 Financial Results
Jun 17, 2024
Keros Therapeutics Announces Leadership Updates
Jun 17, 2024
Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association
Jun 04, 2024
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
Jun 03, 2024
Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
May 28, 2024
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
May 14, 2024
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
Displaying 1 - 10 of 19